MTIP AG

MTIP is a Swiss-based growth capital investor established in 2014, focusing on the healthcare sector. The firm partners with innovative companies in digital health, medical technology, and healthcare services to develop cost-effective and socially responsible solutions that enhance patient care. With the support of experienced investment professionals and a proprietary network of research institutions and medical facilities, MTIP provides both financial and strategic assistance to companies from market entry through their expansion phases. The firm's primary objective is to empower talented entrepreneurs to build successful, sustainable businesses that possess clear competitive advantages.

David Germonpre

Partner

Christoph Kausch

Managing Partner

Erich Platzer

Healthcare Partner and Member of the Board of Directors

22 past transactions

Dossier Solutions

Acquisition in 2024
Dossier is a leading provider of cloud-based competency assurance and management solutions for health systems globally. We drive meaningful, measurable results for more than 500,000 healthcare workers. For more information, please visit www.dossierhealthcare.com.

Caresyntax

Series C in 2024
Caresyntax Inc. is a Boston-based company that provides a digital surgery platform to enhance surgical performance in hospitals and ambulatory surgical centers. Founded in 1991, it leverages data from over 1,600 hospitals globally to deliver insights that improve patient outcomes and operational efficiency. The platform integrates various data sources, including video, audio, clinical, and operational data, enabling real-time analysis and decision-making during surgeries. Caresyntax offers solutions such as qvident, a performance management software, and PRIME365, a comprehensive integration platform that consolidates surgical data and content. With a focus on automating workflows and reducing surgical variability, Caresyntax supports over 4,000 operating rooms and has facilitated millions of surgical procedures worldwide. The company’s HIPAA-compliant software can be deployed on-premise, in the cloud, or in a hybrid format, making it adaptable to diverse healthcare environments.

Hexarad

Series B in 2024
Hexarad is a teleradiology company that specializes in the remote reporting of medical scans, including CTs, MRIs, and X-rays. The company has developed a healthcare technology platform designed to enhance the efficiency of diagnostic services while focusing on patient-centered care. This platform incorporates image analysis algorithms for interpreting medical images and streamlines workflows related to scheduling, assignment, prioritization, and tracking of case progress. Additionally, Hexarad offers telemedicine features that enable remote consultations, allowing radiologists to reduce turnaround times for diagnostic reports. This efficiency leads to quicker treatment decisions and improved patient outcomes.

Nitinotes

Series B in 2023
NitiNotes is a company specializing in innovative medical technology, particularly for the field of gastroenterology. It has developed the EndoZip™, a fully automated gastroscopic suturing system designed to enhance the safety and simplicity of gastrointestinal suturing. This minimally invasive device enables gastroenterologists and surgeons to perform procedures that mimic laparoscopic sleeve gastrectomy, effectively creating a stomach volume restriction to assist patients with obesity in achieving weight loss. The system is intended for patients classified as obesity class I and II, providing an alternative for those who may not qualify for traditional bariatric surgery. By streamlining endoscopic gastroplasty procedures, NitiNotes aims to make effective weight-loss treatments more accessible to a broader range of patients.

Apricity

Series B in 2022
Apricity is a pioneering virtual fertility clinic designed to enhance the fertility treatment experience for individuals and couples facing challenges in conception. By integrating data and artificial intelligence with personalized human care, Apricity aims to improve pregnancy success rates. The clinic offers a patient-centric approach, providing convenient at-home services and appointments that aim to ease the burden of infertility. Led by a team of experienced entrepreneurs, medical professionals, and data scientists, Apricity seeks to disrupt traditional fertility treatment methods and support patients more effectively throughout their journey.

LynxCare

Series A in 2022
LynxCare, Inc. is an AI-powered data platform founded in 2015 and based in San Francisco, California. The company specializes in collecting and analyzing both structured and unstructured data from various sources to deliver actionable insights for medical professionals in hospitals and clinics. LynxCare's platform aggregates clinical data and patient-reported outcomes, providing custom tools that enhance clinical efficiency and improve the quality of care. By enabling healthcare practitioners to mine their legacy data and access real-time information, LynxCare aims to improve healthcare outcomes and tailor patient care effectively.

Mediktor

Venture Round in 2021
Mediktor is a technology company that has developed an advanced pre-diagnosis tool utilizing artificial intelligence and natural language recognition to assist patients in identifying symptoms and potential conditions. The system is designed to facilitate pre-diagnosis, triage, and decision-making support, ultimately transforming healthcare delivery. By empowering patients to make informed decisions based on their initial symptoms, Mediktor aims to reduce barriers to healthcare access. Additionally, the platform enables healthcare providers to effectively manage demand and optimize resources, thereby improving overall medical coverage. By connecting patients with medical professionals within health insurance networks, Mediktor enhances the efficiency and safety of healthcare decisions for hospitals and health systems.

Oviva

Series C in 2021
Oviva UK Limited is a healthcare company based in London that specializes in digitally-enabled behavior change programs focused on diet and lifestyle-related health conditions, particularly type 2 diabetes and obesity. Founded in 2015, Oviva has developed a unique platform that combines a smartphone app and learning portals to provide personalized coaching and nutritional advice. This approach allows patients to engage in behavior change without the need for in-person clinic visits, thereby improving health outcomes and reducing costs for healthcare systems by preventing complications associated with these conditions. By leveraging a network of qualified consultants, Oviva aims to support individuals in achieving better health through tailored interventions.

Intelligencia AI

Series A in 2021
Intelligencia AI is an enterprise SaaS company that specializes in applying machine learning technology to enhance clinical development strategies. The company has developed a cloud-based platform that utilizes predictive analytics to assess, quantify, and mitigate risks associated with clinical trials. By estimating the probability of success for various trial designs, Intelligencia's platform allows healthcare organizations to optimize their approaches before initiating trials. This proactive risk management not only helps to save time and resources for clinical trials but also facilitates quicker access to innovative therapies for patients.

Koa Health

Series A in 2021
Koa Health B.V., founded in 2018 and based in Amsterdam with additional offices in Barcelona, the United States, and the United Kingdom, develops digital solutions aimed at enhancing mental well-being for employees. The company provides a range of products that are informed by the latest clinical research and technology. Its offerings include the koa foundation application, which supports early symptom management and mild mental health issues, and Mindset, a chat-based platform for private mental health support. Koa Health’s solutions encompass prevention, prediction, and treatment, featuring a library of evidence-based activities designed to address various mental health challenges, such as stress management, sleep improvement, and confidence building. By delivering scalable and affordable care, Koa Health aims to make mental health support accessible and effective for individuals and organizations alike.

Lumeon

Series D in 2020
Lumeon Ltd. is a digital health company based in London, United Kingdom, specializing in care pathway management solutions for the healthcare sector. Founded in 2005 and formerly known as Qinec Ltd., Lumeon offers a cloud-based platform called Care Pathway Manager, which provides a comprehensive, real-time overview of the patient journey from referral to outcome. The company's services encompass business analysis, project management, configuration, data migration, training, and ongoing support. By focusing on the entire care pathway, Lumeon enables healthcare providers to unify clinical and administrative workflows, automate tasks, and achieve measurable healthcare outcomes. Its client base includes some of Europe's leading healthcare providers, such as BUPA, Nuffield Health, and HCA, reflecting the company's role in driving healthcare transformation.

Trialbee

Venture Round in 2020
Trialbee AB is a software company based in Malmö, Sweden, established in 2010. It specializes in creating a software as a service (SaaS) solution aimed at enhancing patient matching and engagement for clinical trials. The company focuses on improving the speed and accuracy of patient recruitment through its platform, which allows candidates to search for various clinical trials and offers services such as awareness, pre-screening, and reporting. Trialbee provides comprehensive support for sponsors, contract research organizations (CROs), investigator sites, and patients by offering patient recruitment, enrollment, and retention services, including a resource library and adherence reminders. Its technology is designed to simplify clinical research as a care option, ultimately accelerating drug development for pharmaceutical companies.

Oviva

Series B in 2020
Oviva UK Limited is a healthcare company based in London that specializes in digitally-enabled behavior change programs focused on diet and lifestyle-related health conditions, particularly type 2 diabetes and obesity. Founded in 2015, Oviva has developed a unique platform that combines a smartphone app and learning portals to provide personalized coaching and nutritional advice. This approach allows patients to engage in behavior change without the need for in-person clinic visits, thereby improving health outcomes and reducing costs for healthcare systems by preventing complications associated with these conditions. By leveraging a network of qualified consultants, Oviva aims to support individuals in achieving better health through tailored interventions.

Lumeon

Series C in 2018
Lumeon Ltd. is a digital health company based in London, United Kingdom, specializing in care pathway management solutions for the healthcare sector. Founded in 2005 and formerly known as Qinec Ltd., Lumeon offers a cloud-based platform called Care Pathway Manager, which provides a comprehensive, real-time overview of the patient journey from referral to outcome. The company's services encompass business analysis, project management, configuration, data migration, training, and ongoing support. By focusing on the entire care pathway, Lumeon enables healthcare providers to unify clinical and administrative workflows, automate tasks, and achieve measurable healthcare outcomes. Its client base includes some of Europe's leading healthcare providers, such as BUPA, Nuffield Health, and HCA, reflecting the company's role in driving healthcare transformation.

Nitinotes

Series A in 2018
NitiNotes is a company specializing in innovative medical technology, particularly for the field of gastroenterology. It has developed the EndoZip™, a fully automated gastroscopic suturing system designed to enhance the safety and simplicity of gastrointestinal suturing. This minimally invasive device enables gastroenterologists and surgeons to perform procedures that mimic laparoscopic sleeve gastrectomy, effectively creating a stomach volume restriction to assist patients with obesity in achieving weight loss. The system is intended for patients classified as obesity class I and II, providing an alternative for those who may not qualify for traditional bariatric surgery. By streamlining endoscopic gastroplasty procedures, NitiNotes aims to make effective weight-loss treatments more accessible to a broader range of patients.

Nitinotes

Series A in 2018
NitiNotes is a company specializing in innovative medical technology, particularly for the field of gastroenterology. It has developed the EndoZip™, a fully automated gastroscopic suturing system designed to enhance the safety and simplicity of gastrointestinal suturing. This minimally invasive device enables gastroenterologists and surgeons to perform procedures that mimic laparoscopic sleeve gastrectomy, effectively creating a stomach volume restriction to assist patients with obesity in achieving weight loss. The system is intended for patients classified as obesity class I and II, providing an alternative for those who may not qualify for traditional bariatric surgery. By streamlining endoscopic gastroplasty procedures, NitiNotes aims to make effective weight-loss treatments more accessible to a broader range of patients.

TytoCare

Series C in 2018
TytoCare Ltd. is a healthcare technology company based in Netanya, Israel, with an additional office in New York, New York. Founded in 2011, TytoCare develops handheld devices and applications that facilitate on-demand medical examinations and diagnoses through virtual consultations with healthcare providers. Its product offerings include TytoHome for consumers, TytoPro for healthcare professionals, and TytoClinic for remote care locations. These solutions enable users to perform self-examinations of various body systems, including the heart, lungs, skin, and throat, while providing remote access to physicians for evaluation and treatment of common conditions such as ear infections, flu, and respiratory issues. The platform incorporates a cloud-based data repository, analytics, and machine learning algorithms, enhancing the accuracy and user experience of remote healthcare services. TytoCare has established a strategic partnership with Novant Health to further expand its reach in the telehealth market.

Reactive Robotics

Series B in 2017
Reactive Robotics GmbH, founded in April 2015 and based in Gilching, Germany, specializes in the design, manufacture, and sale of rehabilitation robots aimed at early movement rehabilitation following neurological injuries and orthopedic surgeries. The company focuses on gait rehabilitation for neurological patients and assists orthopedic patients recovering from joint replacements. With a team that has over 12 years of experience in rehabilitation robotics, Reactive Robotics benefits from a robust clinical network and a group of advisors who provide guidance on engineering, legal matters, and medical device registration. Additionally, the company develops AI-driven robotic systems that support very early mobilization therapy, facilitating faster recovery for patients in intensive care units while alleviating the workload of nursing staff.

Blueprint Genetics

Series A in 2017
Blueprint Genetics Oy specializes in clinical genetics testing and diagnostics for rare hereditary diseases using advanced next-generation sequencing (NGS) technology. Founded in 2012 and headquartered in Helsinki, Finland, the company offers a range of services, including tailored sequencing projects and bioinformatics platforms designed to meet specific needs of hospitals and research groups. Blueprint Genetics aims to make genetic diagnostics more accessible by reducing costs while enhancing quality and providing clinical insights in test results. Its product offerings include comprehensive diagnostics for various inherited disorders, including cardiovascular diseases, cancer, and metabolic conditions. The company also maintains an office in Los Angeles, California, and operates as a subsidiary of Quest Diagnostics Incorporated.

Reactive Robotics

Series A in 2016
Reactive Robotics GmbH, founded in April 2015 and based in Gilching, Germany, specializes in the design, manufacture, and sale of rehabilitation robots aimed at early movement rehabilitation following neurological injuries and orthopedic surgeries. The company focuses on gait rehabilitation for neurological patients and assists orthopedic patients recovering from joint replacements. With a team that has over 12 years of experience in rehabilitation robotics, Reactive Robotics benefits from a robust clinical network and a group of advisors who provide guidance on engineering, legal matters, and medical device registration. Additionally, the company develops AI-driven robotic systems that support very early mobilization therapy, facilitating faster recovery for patients in intensive care units while alleviating the workload of nursing staff.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.